Hospital Universitario Dr. Jose E. Gonzalez
Clinical trials sponsored by Hospital Universitario Dr. Jose E. Gonzalez, explained in plain language.
-
New hope for tough leukemia: drug combo aims to boost remission
Disease control Recruiting nowThis study tests a new combination of drugs for people with acute lymphoblastic leukemia that has come back or not responded to treatment. The approach adds a low dose of venetoclax (a targeted drug) and itraconazole to a standard chemotherapy regimen called TACL. The goal is to …
Phase: PHASE2 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated May 17, 2026 01:16 UTC
-
Could a weight-loss drug also calm psoriasis? new trial aims to find out
Disease control Recruiting nowThis study is testing whether semaglutide (a drug used for diabetes and weight loss) can improve psoriasis when added to a standard topical cream. About 62 adults with plaque psoriasis who are overweight or have type 2 diabetes will take either semaglutide or a placebo pill for 1…
Phase: PHASE4 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
New combo aims to boost transplant success in tough lymphoma
Disease control Recruiting nowThis study tests a lower dose of the drug epcoritamab combined with chemotherapy (gemcitabine and oxaliplatin) in people with diffuse large B-cell lymphoma that has come back or not responded to prior treatment. The goal is to see if this combination can shrink tumors enough to a…
Phase: PHASE2 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated May 08, 2026 12:02 UTC